Latest Posts
About This Stock
More About This Stock
Read
Read
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Article By:
Benzinga
Sunday, February 14, 2021 5:56 PM EDT
Biotech stocks advanced in the week ended Feb. 12, thanks to market strength and company-specific catalysts. Small and mid-cap earnings, multiple conference presentations, data readouts, and a slew of IPOs were all part of the week's news flow.
Biotech Digest – GMED Receives Clearance, BIOC Inks New Collaboration, PFE Receives Approval
Article By:
KKD Healthcare Analytics
Friday, August 18, 2017 2:03 PM EDT
Globus Medical Inc. stock perked up as the company announced receiving the 510 (k) clearance from the FDA for Excelsius GPS. AstraZeneca announced receiving the FDA approval for its Lynparzaa. Pfizer has FDA approval for its Besponsa.